Beliefs among physicians in the diagnostic and therapeutic approach to non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 2, Issue 9, 2007, Pages 819-826

  Stinchcombe, Thomas E ^a   Detterbeck, Frank C ^c,d   Lin, Li ^b   Rivera, M Patricia ^a   Socinski, Mark A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b IL   (United States)

^c YALE UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Combined modality therapy; Evidence based medicine; Positron emission tomography scan; Quality of life; Survey

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL PRACTICE; CONTROLLED STUDY; E-MAIL; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; LUNG NODULE; LUNG NON SMALL CELL CANCER; MALE; MEDIASTINUM LYMPH NODE; MEDICAL SOCIETY; PHYSICIAN ATTITUDE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; UNITED STATES;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL COMPETENCE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; UNITED STATES;

EID: 34548398879     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31811f478a     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Schroen A, Detterbeck F, Rivera M, et al. Beliefs among pulmonologists and thoracic surgeons in the therapeutic approach to non-small cell lung cancer therapy. Chest 2000;118:129-137.
3. American College of Chest Physicians; Health and Science Policy Committee. Diagnosis and management of lung cancer: ACCP evidence-based guidelines. Chest 2003;123:D-G, 1S-337S.
4. Bach PB, Niewoehner DE, Black WC. Screening for lung cancer: the guidelines. Chest 2003;123:83S-88S.
5. Sladden MJ, Ward JE. Do Australian family physicians screen smokers for lung cancer? Chest 1999;115:725-728.
6. Kamposioras K, Casazza G, Mauri D, et al. Screening chest radiography: results from a Greek cross-sectional survey. BMC Public Health 2006;6:113.
7. 1989 survey of physicians' attitudes and practices in early cancer detection. CA Cancer J Clin 1990;40:77-101.
8. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259-265.
9. Diederich S, Wormanns D. Impact of low-dose CT on lung cancer screening. Lung Cancer 2004;45 (suppl 2):S13-S19.
10. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
11. Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-1771.
12. Bach PB, Jett JR, Pastorino U, et al. Computed tomography screening and lung cancer outcomes. JAMA 2007;297:953-961.
13. Mountain C. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717.
14. Jennens RR, de Boer R, Irving L, et al. Differences of opinion: a survey of knowledge and bias among clinicians regarding the role of chemotherapy in metastatic non-small cell lung cancer. Chest 2004;126:1985-1993.
15. Tan BB, Flaherty KR, Kazerooni EA, Iannettoni MD. The solitary pulmonary nodule. Chest 2003;123:89S-96S.
16. Detterbeck FC, DeCamp Jr, MM Kohman LJ, Silvestri GA. Lung cancer. Invasive staging: the guidelines. Chest 2003;123:167S-175S.
17. Detterbeck FC, Falen S, Rivera MP, et al. Seeking a home for a PET, part 2: Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer. Chest 2004;125:2300-2308.
18. MacManus MP, Hicks RJ, Matthews JP, et al. High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 2001;50:287-293.
19. Robinson LA, Wagner H Jr, Ruckdeschel JC. Treatment of stage IIIA non-small cell lung cancer. Chest 2003;123:202S-220S.
20. Langer CJ, Moughan J, Movsas B, et al. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? Lung Cancer 2005;48:93-102.
21. Green MR, Andrews M, Leff R, et al. Adjuvant therapy choices in patients with resected non-small-cell lung cancer: correlation of doctors' treatment plans and relevant phase III trial data. J Oncol Pract 2005;1:37-42.
22. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998;352:257-263.
23. Lally BE, Zelterman D, Colasanto JM, et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006;24:2998-3006.
24. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360.
25. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-2597.
26. Douillard JY, Rosell R, Delena M, et al. ANITA: phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small cell lung cancer (NSCLC) patients: final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association [abstract]. J Clin Oncol 2005;23:7013.
27. Socinski MA, Morris DE, Masters GA, Lilenbaum R. Chemotherapeutic management of stage IV non-small cell lung cancer. Chest 2003;123:226S-243S.
28. Perez EA. Perceptions of prognosis, treatment, and treatment impact on prognosis in non-small cell lung cancer. Chest 1998;114:593-604.
29. Ramsey SD, Howlader N, Etzioni RD, Donato B. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare. J Clin Oncol 2004;22:4971-4978.
30. Dornbusch D, Allegra C, Willey J, et al. How do U.S. medical oncologists learn and apply new clinical trials information from press releases in nonmedical media? A case study based on ECOG 4599. Oncologist 2006;11:31-38.
31. Kellerman SE, Herold J. Physician response to surveys. A review of the literature. Am J Prev Med 2001;20:61-67.
32. Akl EA, Maroun N, Klocke RA, et al. Electronic mail was not better than postal mail for surveying residents and faculty. J Clin Epidemiol 2005;58:425-429.